Diabetes Clinical Trials in Dallas

Showing 141-160 of 284 trials

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

NCT00232583

The study evaluates the rate beta-cell function decline in newly diagnosed type 2 diabetic patients on two different treatment regimens: insulin and metformin versus glyburide, metformin and pioglitazone.

Type 2 Diabetes Mellitus

University of Texas Southwestern Medical Center58 participantsStarted Nov 2003

Dallas, Texas, United States

COMPLETEDPHASE2< 1 mile

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

NCT00495469

This is a dose-ranging study to evaluate the efficacy, safety and tolerability of a range of doses of GSK189075 (an SGLT2 inhibitor) compared to placebo, administered over 12 weeks in treatment-naive subjects with type 2 diabetes mellitus

Diabetes Mellitus, Type 2

GlaxoSmithKline250 participantsStarted Aug 2007

Mesa, Arizona, United States • Artesia, California, United States • Buena Park, California, United States +154 more locations

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Diabetes Trials in Other Cities

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Study In People With Type 2 Diabetes

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

A Study of LY2405319 in Participants With Type 2 Diabetes

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Other Conditions in Dallas